LncRNA SNHG15 modulates gastric cancer tumorigenesis by impairing miR-506-5p expression. Issue 7 (30th July 2021)

• Record Type: Journal Article
• Authors: Chen, Zhiping; Zhong, Tianyu; Li, Tao; Zhong, Jinghua; Tang, Yang; Liu, Zhanyu; Ling, Baodian; Wang, Lanfeng
• Is Part Of: Bioscience reports. Volume 41:Issue 7(2021)
• Publication Date: 2021-07-30
• Subjects: Apoptosis -- Gastric cancer -- LncRNA SNHG15 -- MicroRNA-506-5p -- Proliferation; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20204177
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract: The gastric cancer (GC) patients commonly have a poor prognosis due to its invasiveness and distant metastasis. Growing evidence proved that aberrant long non-coding RNAs (lncRNAs) expression contributes to tumor development and progression. LncRNA SNHG15 has been reported to be involved in many different kinds of cancer, while its role in GC remains unclear. In the present study, we found that SNHG15 was up-regulated in GC tissues and cell lines. Silencing SNHG15 suppressed proliferation migration, invasion and promoted apoptosis of AGS cells. More importantly, microRNA-506-5p (miR-506-5p) was predicted as a direct target of SNHG15 by binding its 3′-UTR and further verified using luciferase reporter assay. Meanwhile, the results of rescue experiments revealed that knockdown of miR-506-5p expression reversed the functional effects of SNHG15 silenced cell proliferation, migration, invasion and apoptosis. In conclusion, our findings revealed that SNHG15 executed oncogenic properties in GC progression through targeting miR-506-5p, which might provide a novel target for the GC treatment.